Reports Q4 revenue $1.3B, consensus $1.27B. "We delivered growth in Net Sales and Adjusted EBITDA in 2022 despite a challenging fourth quarter during which we faced higher raw material costs and demand weakness in Europe and Asia, leading to lower operating rates. In 2022, we achieved a number of milestones, including record Net Sales and Adjusted EBITDA in both our TSS and APM segments," said Chemours CEO Mark Newman.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on CC: